Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Patient Guides COVID19 1000x250

Outpatient visits

High priority

Your outpatient appointment may be a high priority if:

  • You have recently been diagnosed with a primary brain tumour
  • You are experiencing a new symptom, or a worsening symptom, that might be caused by a cancer-related or treatment-related complication. Examples of these include neurological symptoms, dyspnoea and chest pain
  • There is evidence that you may be experiencing a recurrence of your cancer
  • The purpose of your appointment is for administration of an intravenous or intrathecal anticancer treatment
  • You have undergone surgery for a brain tumour and the wound is not healing properly

Medium priority

Your outpatient appointment may be a medium priority if:

  • shutterstock_1710518023
    You are receiving active treatment for a brain tumour but have no new or worsening symptoms, and the purpose of your appointment is to discuss laboratory or imaging results. In these cases, appointments may be conducted via telephone
  • The purpose of your appointment is to obtain a prescription for oral anticancer treatment. In these cases, appointments may be conducted via telephone
  • You have undergone surgery for a brain tumour but are not experiencing any complications, and are not currently receiving active treatment

Low priority

Your outpatient appointment may be a low priority if:

  • You are not currently receiving active treatment, have no new or worsening symptoms, and the purpose of your appointment is to discuss laboratory or imaging results. In these cases, appointments may be conducted via telephone
  • You are receiving best supportive care and the purpose of your appointment is for a routine follow-up visit
  • The purpose of your appointment is for psychological support. In these cases, appointments may be conducted via telephone
  • You were successfully treated for a brain tumour in the past and the purpose of your appointment is for a routine follow-up visit
  • The purpose of your appointment is for a second opinion. In these cases, appointments may be conducted via telephone

Imaging

High priority

Your appointment may be a high priority if:

  • shutterstock_722800864
    You need imaging to investigate new or worsening neurological symptoms

Medium priority

Your appointment may be a medium priority if:

  • You are receiving ongoing anticancer treatment and are due to have imaging as part of your follow-up schedule, but you are not experiencing any new or worsening symptoms

Low priority

Your appointment may be a low priority if:

  • You are not currently receiving anticancer treatment and are due to have imaging as part of your follow-up schedule, but you are not experiencing any new or worsening symptoms

Surgery

High priority

Your appointment may be a high priority if:

  • You need surgery to reduce pressure on the brain
  • You are scheduled to undergo surgery for suspected glioma
  • You need a biopsy to investigate a suspected central nervous system lymphoma

Medium priority

Your appointment may be a medium priority if:

  • You are scheduled to undergo resection or biopsy of a non-contrast enhancing primary brain tumour, but your neurological symptoms are currently stable
  • You are scheduled to undergo a repeat resection of a low-grade glioma

Low priority

Your appointment may be a low priority if:

  • You are scheduled to undergo partial resection for a recurrence of glioma

Radiotherapy

High priority

Your appointment may be a high priority if:

  • shutterstock_1127948867
    You are scheduled to undergo radiotherapy to treat a newly diagnosed isocitrate dehydrogenase (IDH)-wild type glioblastoma
  • You are scheduled to undergo radiotherapy to treat a low-grade IDH-mutant glioma and are experiencing symptoms
  • You are scheduled to undergo radiotherapy for adult medulloblastoma

Medium priority

Your appointment may be a medium priority if:

  • You are scheduled to undergo radiotherapy to treat a low-grade IDH-mutant glioma

Low priority

Your appointment may be a low priority if:

  • You are scheduled to undergo additional radiotherapy to re-treat a glioma

Medical management of primary brain tumours

High priority

Your appointment may be a high priority if:

  • You have recently been diagnosed with primary central nervous system lymphoma and are scheduled to receive high-dose chemotherapy with methotrexate
  • You have recently been diagnosed with glioblastoma with MGMT promoter methylation and are scheduled to receive concurrent and adjuvant temozolomide with radiotherapy
  • You have IDH-mutant 1p19q-intact anaplastic astrocytoma and are scheduled to receive adjuvant temozolomide after radiotherapy
  • shutterstock_1140298433
    You have recently been diagnosed with 1p19q-codeleted anaplastic oligodendroglioma and are scheduled to receive treatment with adjuvant alkylating chemotherapy after radiotherapy
  • You have a recurrence of glioma with MGMT promoter methylation and are scheduled to receive treatment with alkylating chemotherapy
  • You require treatment with steroids. The use of steroids will be limited as far as possible during the COVID‑19 pandemic to minimise the use of immunosuppressive drugs

Medium priority

Your appointment may be a medium priority if:

  • You have recently been diagnosed with glioblastoma without MGMT promoter methylation and are scheduled to receive concurrent and adjuvant temozolomide with radiotherapy
  • You are scheduled to receive systemic treatment for a brain tumour that is progressing, but there is no evidence that the treatment is effective for your specific type of tumour (for example, meningioma or adult ependymoma)
  • You are scheduled to receive adjuvant alkylating chemotherapy after radiotherapy for IDH-mutant grade II astrocytoma
  • You are scheduled to receive adjuvant chemotherapy after radiotherapy for adult medulloblastoma

Low priority

Your appointment may be a low priority if:

  • You are scheduled to receive alkylating chemotherapy for a recurrence of glioma without MGMT promoter methylation
  • You are scheduled to receive alkylating chemotherapy for a second (or higher) recurrence of glioma
  • You are scheduled to receive alkylating chemotherapy but your general health is poor or you are elderly

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings